stockrowCVS Health Corporation
CVS Healthcare Healthcare Plans
CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024.
- Revenue
- +5.37%
- EPS
- +154.1%
- Free cash flow
- +3,886.7%
- Total debt
- −7.83%
Quarter to September 2026, against a year earlier
Follow CVS
Alert me
CVS Health Corporation (CVS) EBITDA
CVS Health Corporation's EBITDA for fiscal 2025 was $15.0B, up 14.3% from $13.1B in fiscal 2024. Over the twelve months to 30 September 2026 it was $19.6B. Over the past ten years it has ranged from $11.6B (fiscal 2015) to $18.4B (fiscal 2020); the current reading is higher than 64% of that period. CVS Health Corporation ranks 2nd of 12 Healthcare Plans companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2025 | $15.0B | 14.32% |
| FY2024 | $13.1B | (27.59%) |
| FY2023 | $18.1B | 48.70% |
| FY2022 | $12.2B | (33.19%) |
| FY2021 | $18.2B | (0.68%) |
| FY2020 | $18.4B | 12.19% |
| FY2019 | $16.4B | 26.92% |
| FY2018 | $12.9B | 5.66% |
| FY2017 | $12.2B | (5.16%) |
| FY2016 | $12.9B | 11.19% |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Sep 2026 | $4.7B | (19.40%) |
| Jun 2026 | $5.8B | 0.59% |
| Mar 2026 | $5.8B | 77.82% |
| Dec 2025 | $3.3B | (10.76%) |
| 43 more quarters | Free account |
Against its own ten years
EBITDA against peers
| Company | EBITDA |
|---|---|
| UNH UnitedHealth Group Incorporated compare | $28.2B |
| CVS CVS Health Corporation | $19.6B |
| CI Cigna Group compare | $12.7B |
| ELV Elevance Health, Inc. compare | $9.2B |
| HUM Humana Inc. compare | $3.1B |
| CNC Centene Corporation compare | $2.2B |
| OSCR Oscar Health, Inc. compare | $632.0M |
| MOH Molina Healthcare, Inc compare | $333.0M |
| PGNY Progyny, Inc. compare | $117.9M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on CVS
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement